Fuxiao Wang
Impact in
- Orthopedics and Sports Medicine top 10%
-
- MicroRNA in disease regulation
Papers in
-
- Extracellular vesicles in disease 5
- Bone Metabolism and Diseases 4
- Advanced biosensing and bioanalysis techniques 2
-
- Bone Tissue Engineering Materials 6
- 3D Printing in Biomedical Research 4
- Co-authors
- Jiacan Su (18 shared papers)Han Liu (4 shared papers)Long Bai (8 shared papers)Yan Hu (4 shared papers)Shihao Sheng (3 shared papers)Xiao Chen (3 shared papers)Jiawei Guo (2 shared papers)Hao Zhang (1 shared paper)
- Journals
- Bioactive Materials (2 papers)Chemical Engineering Journal (2 papers)Virtual and Physical Prototyping (1 paper)Cell Reports Medicine (1 paper)Military Medical Research (1 paper)
- Partner nations
- ChinaUnited KingdomSingapore
In The Last Decade
Fuxiao Wang
17 papers receiving 377 citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Orthopedics and Sports Medicine 44
- Cancer Research 58
- Biomaterials 48
- Molecular Biology 226
- Microbiology 19
Countries citing papers authored by Fuxiao Wang
This map shows the geographic impact of Fuxiao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuxiao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuxiao Wang more than expected).
Fields of papers citing papers by Fuxiao Wang
This network shows the impact of papers produced by Fuxiao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuxiao Wang. The network helps show where Fuxiao Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Fuxiao Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases Hit paper breakdown → | 2023 | 129 |
| 2 | 2024 | 45 | |
| 3 | 2023 | 32 | |
| 4 | 2024 | 31 | |
| 5 | 2023 | 30 | |
| 6 | 2020 | 19 | |
| 7 | 2021 | 13 | |
| 8 | 2023 | 13 | |
| 9 | 2025 | 11 | |
| 10 | 2024 | 10 | |
| 11 | 2025 | 10 | |
| 12 | 2025 | 9 | |
| 13 | 2024 | 9 | |
| 14 | 2018 | 9 | |
| 15 | 2024 | 7 | |
| 16 | 2022 | 5 | |
| 17 | 2025 | 1 | |
| 18 | 2025 | 0 | |
| 19 | 2025 | 0 | |
| 20 | 2025 | 0 |
About Fuxiao Wang
Fuxiao Wang is a scholar working on Molecular Biology, Biomedical Engineering, Surgery, Oncology and Genetics, having authored 20 papers that have together received 383 indexed citations. Recurring topics across this work include Bone Tissue Engineering Materials (6 papers), Extracellular vesicles in disease (5 papers), 3D Printing in Biomedical Research (4 papers), Bone Metabolism and Diseases (4 papers), Tissue Engineering and Regenerative Medicine (3 papers), Advanced biosensing and bioanalysis techniques (2 papers), MicroRNA in disease regulation (2 papers) and Bone health and treatments (2 papers). The work is most often cited by research in Orthopedics and Sports Medicine (44 citations), Cancer Research (58 citations), Biomaterials (48 citations), Molecular Biology (226 citations) and Microbiology (19 citations). Fuxiao Wang has collaborated with scholars based in China, United Kingdom and Singapore. Frequent co-authors include Jiacan Su, Han Liu, Long Bai, Yan Hu, Shihao Sheng, Xiao Chen, Jiawei Guo, Hao Zhang, Tao Zhang and Yan Wei. Their work appears in journals such as Bioactive Materials, Chemical Engineering Journal, Virtual and Physical Prototyping, Cell Reports Medicine and Military Medical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.